LUMBY, BC, Oct. 2 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the stations that will feature their Neuroskin(R) Psoriasis Relief DRTV commercial during the two week media test.
avVaa World Health Care Products Inc. is launching a two week DRTV media test run for Neuroskin(R) Psoriasis Relief beginning the week of October 5, 2009. Over one hundred 120, 60, and 30 second commercials will be run during the two week period. The following stations will host a total of 102 scheduled commercials:
Bloomberg - 3 Chiller - 5 CLTV - 16 Gameshow - 2 History International - 6 Military Channel - 7 New England Cable News - 15 Ovation - 20 Sleuth - 7 Tennis - 11 THIS TV - 4 Universal Sports - 6
avVaa's media buyer has also negotiated a number of free 60 second commercials on the same stations. These free commercials are not scheduled in advance, but are expected to total an additional 30 to 40 commercials over the two week period. This will expand avVaa's Neuroskin Psoriasis Relief DRTV test run by about 20% at no additional charge.
The channels chosen for the media test have a subscriber base of 380 million households. National channels were chosen for their large subscriber base and preferred demographic. Regional channels chosen can offer the commercials at a higher frequency. The majority of the commercials will be shown in the daytime.
avVaa President and Chief Operating Officer Lorie Campbell-Farley confirmed that all support systems are ready for the media test. "Our credit card processing, call center and website are all up and running smoothly. Our distribution company has nearly 17,000 bottles of Neuroskin Psoriasis Relief on site. We're set to take off running."
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.
Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
CONTACT: avVaa World Health Care Products, Jack Farley, Chairman/CEO, email@example.com; Lorie Campbell-Farley, President/COO, firstname.lastname@example.org; Investor Relations: Merle Goertz (West Coast), (604) 688-2349
SOURCE avVaa World Health Care Products
|SOURCE avVaa World Health Care Products|
Copyright©2009 PR Newswire.
All rights reserved